Osterziel K J, Dietz R, Abushi A, Kübler W
Innere Medizin III (Schwerpunkt Kardiologie, Angiologie und Pulmologie), Medizinische Universitätsklinik Heidelberg.
Z Kardiol. 1990 Nov;79(11):742-7.
In 33 patients with heart failure (NYHA II-III) 24-h blood pressure was examined during the titration of two ACE-inhibitors. Blood pressure was measured by the oscillometric method using the blood pressure monitor 90202 from SpaceLabs, Inc. The measurements were taken from 06.00 to 22.00 hours every 20 min, and from 22.00 to 06.00 hours every 1 h. All patients received an additional therapy, either with captopril (group 1, n = 17) or enalapril (group 2, n = 16) in random order. Serum-electrolytes, serum-creatinine, and plasma-renin activity were measured before and during therapy with both ACE-inhibitors. 24-h blood pressure measurements were taken before and on the first and fifth day of the treatment with ACE-inhibitors. The groups did not different in respect to the degree of heart failure, the concomitant medication, or the 24-h profiles of blood pressure and heart rate. The mean initial doses of captopril was 9.2 +/- 1.2 mg. Each patient of group 2 received an initial dose of 2.5 mg enalapril. The maximal decrease of diastolic blood pressure occurred after 1 h in group 1 and after 4 h in group 2 and was similar in both groups (8 vs, 7 mmHg). The 24-h blood pressure values on day 5 were consistently below the pretreatment values (p less than 0.005). Heart rate was not affected by either ACE-inhibitor. The groups did not differ significantly during ACE-inhibition in their 24-h blood pressure and heart rate profiles. Before treatment, serum-sodium, -potassium and -creatinine were within the normal range.(ABSTRACT TRUNCATED AT 250 WORDS)
在33例心力衰竭(纽约心脏协会II-III级)患者中,在两种血管紧张素转换酶抑制剂(ACE抑制剂)滴定过程中检测24小时血压。使用太空实验室公司的90202型示波法血压监测仪测量血压。测量时间为06:00至22:00每20分钟一次,22:00至06:00每小时一次。所有患者均接受额外治疗,随机顺序使用卡托普利(第1组,n = 17)或依那普利(第2组,n = 16)。在使用两种ACE抑制剂治疗前和治疗期间测量血清电解质、血清肌酐和血浆肾素活性。在使用ACE抑制剂治疗前、治疗第一天和第五天进行24小时血压测量。两组在心力衰竭程度、伴随用药或24小时血压和心率曲线方面无差异。卡托普利的平均初始剂量为9.2±1.2毫克。第2组的每位患者接受2.5毫克依那普利的初始剂量。第1组舒张压最大降幅出现在1小时后,第2组出现在4小时后,两组相似(8对7毫米汞柱)。第5天的24小时血压值持续低于治疗前值(p<0.005)。心率不受任何一种ACE抑制剂的影响。在ACE抑制期间,两组的24小时血压和心率曲线无显著差异。治疗前,血清钠、钾和肌酐在正常范围内。(摘要截短于250字)